share_log

港股异动 | 再鼎医药-SB(9688.HK)续升超7% 6日累计涨幅达40%

Changes in Hong Kong stocks | Zai Lab Limited-SB (9688.HK) continued to rise by more than 7%, with a cumulative increase of 40% for 6 days.

Gelonghui Finance ·  Jun 24, 2022 09:40
On June 24th, Zai Lab Limited-SB (9688.HK) rose 7.58% again, and the cumulative increase on the 6th was as high as 40%. The total market value is now HK $25.55, and the total market capitalization is back to HK $25 billion.
The voluntary conversion of the company's secondary listing status on the Hong Kong Stock Exchange to a dual major listing on the Hong Kong Stock Exchange on June 27 will take effect. The company will become a dual major listed company on the Hong Kong Stock Exchange and the NASDAQ global market, and the stock mark "S" will be deleted from its stock abbreviation.
From the company's point of view, dual listing expands its shareholder base and enhances the influence of the global market.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment